Evidence map›Paper›PMID 30389773›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Mitochondrial Deacetylase SIRT3 Plays an Important Role in Donor T Cell Responses after Experimental Allogeneic Hematopoietic Transplantation.

Tomomi Toubai, Hiroya Tamaki, Daniel C Peltier, Corinne Rossi, Katherine Oravecz-Wilson, Chen Liu, Cynthia Zajac, Julia Wu, Yaping Sun, Hideaki Fujiwara and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Roles of SIRT3 in aging and aging-related diseases.International journal of biological sciences · 2025
    Review
  5. Article
  6. The role of SIRT3 in homeostasis and cellular health.Frontiers in cellular neuroscience · 2024
    Review
  7. Article
  8. Role of Histone Deacetylases in T-Cell Development and Function.International journal of molecular sciences · 2022
    Review
  9. Review
  10. hPMSCs inhibit the expression of PD-1 in CD4Stem cell research & therapy · 2021
    Article
  11. Role of Epigenetics in the Regulation of Immune Functions of the Skin.The Journal of investigative dermatology · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy.Frontiers in cell and developmental biology · 2020
    Review
  18. Review
  19. Review
  20. Regulation of Adaptive Immune Cells by Sirtuins.Frontiers in endocrinology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Tomomi ToubaiDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
Hiroya TamakiDivision of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo 663-8131, Japan.
Daniel C PeltierDivision of Hematology and Oncology, Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109.
Corinne RossiDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
Katherine Oravecz-WilsonDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
Chen LiuDepartment of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, North Bergen, NJ 08903; and.
Cynthia ZajacDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.ORCID 0000-0003-2983-4175
Julia WuDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.ORCID 0000-0002-6671-2217
Yaping SunDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
Hideaki FujiwaraDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
Israel HenigDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
Stephanie KimDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109.
David B LombardDepartment of Pathology and Institute of Gerontology, University of Michigan, Ann Arbor, MI 48109.
Pavan ReddyDivision of Hematology and Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109; reddypr@med.umich.edu.
University of Michigan · USHeidelberg University · DEHyogo Medical University · JPRutgers, The State University of New Jersey · US

Funding

Advancing Child Health Through Cellular and Molecular BiologyK12HD028820 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Donna M. Martin · 2002 to 2026
$9.2M
Targeting antigen presentation to enhance GVL responses after Bone Marrow TransplR01HL090775 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2008 to 2016
$3.4M
Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severityR01CA203542 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2016 to 2020
$2.4M
Development of novel strategy for treatment of steroid refractory GVHDR01HL128046 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2015 to 2019
$2.1M
Role of noncoding RNA in Regulating GVHDR01CA173878 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2013 to 2017
$1.6M
Development of a Novel Strategy to Prevent Experimental GVHDR01CA143379 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI REDDY, PAVAN · 2010 to 2014
$739k
NCI NIH HHS R01 CA143379NCI NIH HHS R01 CA173878NCI NIH HHS R01 CA203542NHLBI NIH HHS R01 HL090775NHLBI NIH HHS R01 HL128046NICHD NIH HHS K12 HD028820
6 · The paper itself

Abstract

Allogeneic hematopoietic cell transplantation (allo-HCT) through its graft-versus-tumor (GVT) effects is a curative therapy against many hematological malignancies. However, GVT is linked to harmful graft-versus-host disease (GVHD) after allo-HCT. Both GVT and GVHD require allogeneic T cell responses, which is an energetically costly process that causes oxidative stress. Sirtuin 3 (SIRT3), a mitochondrial histone deacetylase (HDAC), plays an important role in cellular processes through inhibition of reactive oxygen species (ROS). Nonmitochondrial class of HDACs regulate T cell responses, but the role of mitochondrial HDACs, specifically SIRT3, on donor T cell responses after allo-HCT remains unknown. In this study, we report that SIRT3-deficient (SIRT3

Indexed as

Bone Marrow TransplantationGraft vs Tumor EffectHematopoietic Stem Cell TransplantationAnimalsCells, CulturedGraft vs Host DiseaseHumansIsoantigensMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMitochondriaModels, AnimalSirtuin 3Tissue DonorsIsoantigensSirtuin 3

Identifiers

PMID30389773
PMCPMC6240608
OpenAlexW2899207149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.